How Xialla Addresses Veno-Occlusive Dysfunction

Venous leak — also called veno-occlusive dysfunction (VOD) or corporoveno-occlusive dysfunction (CVOD) — occurs when blood enters the corpora cavernosa adequately but escapes too quickly through the venous system. Sustained intracavernosal pressure cannot build, and the erection fades. This article summarizes the physiology, why common therapies often underperform when outflow is the problem, and how an anchored constriction device is intended to help.

Inflow and outflow

Sexual arousal triggers nitric oxide–mediated relaxation of cavernosal smooth muscle and dilation of the cavernosal arteries. Blood fills the sinusoidal spaces. As the corpora expand, they compress subtunical venules and emissary veins against the tunica albuginea. That compression is the veno-occlusive mechanism.

Additional drainage pathways include the deep dorsal vein, circumflex veins, and para-arterial veins. As long as arterial inflow exceeds venous outflow, pressure rises to levels that support rigidity. Detumescence follows sympathetic activation, smooth-muscle contraction, and restoration of venous drainage.

Pathophysiology of veno-occlusive dysfunction

VOD occurs when the occlusive mechanism fails despite adequate (or even enhanced) arterial inflow. Contributing mechanisms include:

• Reduced compliance or fibrosis of the tunica albuginea or trabecular smooth muscle (age, diabetes, androgen deficiency)
• Incomplete smooth-muscle relaxation from endothelial dysfunction or excessive adrenergic tone
• Venous shunts or congenital/acquired abnormalities that bypass the compression zone
• Post-prostatectomy or pelvic surgery effects — nerve injury, fibrosis, or altered hemodynamics that produce secondary VOD

Clinically, men with predominant VOD often report good initial tumescence that diminishes during intercourse. Color Doppler ultrasound after intracavernosal vasoactive injection typically shows normal peak systolic velocity with elevated end-diastolic velocity, indicating poor venous trapping.

A venous component contributes to a substantial proportion of vasculogenic ED. Figures in the literature vary by cohort; a perspective article on Xialla describes venous leak as an etiological factor contributing to approximately 75% of ED cases, citing Kaba & Pearce. That means venous leak is present and contributing in a large share of cases, not that it is the sole cause in that share.

Limits of common therapies

PDE5 inhibitors enhance arterial inflow. They cannot fully compensate for excessive outflow. A substantial subset of men achieve only partial or unsustained responses when VOD is significant.

Venous ligation or embolization has shown disappointing long-term durability in many series. Major guidelines generally do not recommend venous surgery as routine care for ED. See What the AUA Guideline Says About Venous Leak.

Why conventional rings are limited

Traditional constriction rings compress veins at the base externally. During thrusting, low-friction skin sliding over deeper tissues can move the ring, so occlusion becomes inconsistent. Excessive tightening risks ischemia, numbness, or discomfort and can restrict arterial inflow. A scrotal loop alone does not provide a fixed external anchor because the scrotum moves with the penile skin.

How Xialla’s anchoring works

Xialla is soft medical-grade silicone. An adhesive pad on the lower back, a ring at the penile base, and a scrotal loop locked to a band draw the device rearward and hold it against the body. Position is maintained by traction rather than by circumferential tightness alone, so occlusion can be effective at lower compression and is less likely to be lost during movement.

The device can be applied flaccid or erect and can be used alone or with an inflow treatment (oral medication, injection, or vacuum device). Related mechanism pages: Blood Retention and How Xialla Works to Correct Venous Leak.

Clinical evidence

Xialla is an FDA-registered Class II medical device (external penile rigidity device classification).

A clinical evaluation led by Dr. Anthony J. Bella, presented at the World Meeting on Sexual Medicine in 2016, reported enhancement of erectile function in 14 of 21 patients. A subsequent evaluation reported satisfactory treatment salvage in 6 of 11 men with confirmed veno-occlusive dysfunction. Both are described in the 2024 International Journal of Impotence Research perspective by Yafi, Hammad, and Elterman.

These are small evaluations, not randomized controlled trials. The published discussion states that larger multicentre trials are needed.

Read the paper: Int J Impot Res or the PMC version.

Who it is relevant for

Men with suspected VOD on history or Doppler findings, partial PDE5i response, or post-prostatectomy ED where retention is impaired. It is not a treatment for pure arterial insufficiency, neurological failure to initiate erection, or hormonal causes, and it is not a cure for venous leak — it manages outflow while worn.

Combination with PDE5 inhibitors, vacuum devices (as the retention ring), or injections is common in practice; confirm combinations with a physician.

Safe use

Maximum continuous wear is 30 minutes; remove before sleeping; remove immediately if numbness, coldness, discoloration, or pain occurs. Men taking anticoagulant or antiplatelet medication, men with sickle cell disease or another bleeding or clotting disorder, men with a history of priapism, and men with reduced penile sensation should consult a physician before use. See using a constriction device safely.

References

• Yafi FA, Hammad MAM, Elterman D. Xialla: a novel medical device for addressing erectile dysfunction associated with veno-occlusive dysfunction. Int J Impot Res. 2024;36:551-552. Full text
• Kaba R, Pearce I. Venous leak and erectile dysfunction: an important differential. J Clin Urol. 2020;13(1):33–39.
• Panchatsharam PK, et al. Physiology, Erection. StatPearls. 2023.
• Burnett AL, Nehra A, Breau RH, et al. Erectile Dysfunction: AUA Guideline. J Urol. 2018;200(3):633-641.
• Dean RC, Lue TF. Physiology of Penile Erection and Pathophysiology of Erectile Dysfunction. Urol Clin North Am. 2005.

If you have questions about anything in this article, write to us at hello@xialla.com. We read and answer every message.